Oscillating Positive Expiratory Pressure Devices Market Global Report 2028
振動式呼気陽圧(OPEP)装置市場は、2021年の1億2,566万米ドルから2028年には1億7,934万米ドルに成長すると予測されており、2021年から2028年にかけて5.2%のCAGRで成長すると推定されています。expiratory pressure (OPEP) devices market is projected to grow from US$ 125.66 million in 2021 to US$ 179.34 million by 2028; it is estimated to grow at a CAGR of 5.2% during 2021–2028.
振動式呼気陽圧(OPEP)装置は、咳ができない人、特に慢性疾患を持つ人の呼吸器分泌物の除去を助けるため、従来の胸部理学療法(CPT)の補助として使用されてきました。嚢胞性線維症、気管支拡張症、気管支炎、気管支喘息、原発性繊毛機能不全症候群などの慢性気道疾患では、OPEP装置の使用はまだ制限されています。慢性閉塞性肺疾患(COPD)では、振動式呼気陽圧(OPEP)装置が痰の除去に役立ちます。expiratory pressure (OPEP) devices have been in use as a supplement to traditional chest physiotherapy (CPT) to aid the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. The use of OPEP devices is still limited in chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices help with sputum clearance.
振動式呼気陽圧呼吸(OPEP)装置市場のexpiratory pressure (OPEP) devices market成長は、慢性閉塞性肺疾患(COPD)と喘息の罹患率の増加と医療技術の進歩に起因しています。しかし、OPEP装置に対する認知度の低さとアクセスの制限が市場の成長を妨げています。OPEP devices hinder the growth of the market.
要件に合わせて調査をカスタマイズ
弊社の標準サービスでは対応できない分析と範囲を最適化し、カスタマイズすることができます。この柔軟性により、ビジネス計画と意思決定に必要な正確な情報を得ることができます。
振動式呼気陽圧(OPEP)デバイス市場:
Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Strategic Insights
Oscillating Positive Expiratory Pressure (OPEP) Devices Market
-
CAGR (2021 - 2028)
5.2%
-
Market Size 2021
US$ 125.66 Million
-
Market Size 2028
US$ 179.34 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Allergan Plc
- PARI GmbH
- Smiths Medical
- AirPhysio
- D R BURTON HEALTHCARE
- Medica Holdings LLC
- CEGLA Medizintechnik GmbH Co KG
- Able Healthcare
- Trudell Medical International
Regional Overview
- 北米(米国、カナダ、メキシコ)
- ヨーロッパ(英国、ドイツ、フランス、ロシア、イタリア、その他のヨーロッパ)
- アジア太平洋(中国、インド、日本、オーストラリア、その他のアジア太平洋)
- 南米および中米(ブラジル、アルゼンチン、その他の中南米)
- 中東およびアフリカ(南アフリカ、サウジアラビア、UAE、その他の中東およびアフリカ)
Market Segmentation
製品(マウスピースPEPデバイス、フェイスマスクPEPデバイス、ボトルPEPデバイス)
適応症(慢性閉塞性肺疾患(COPD))
喘息、気管支炎、気管支拡張症、嚢胞性線維症など
流通チャネル(病院薬局、オンライン薬局、小売薬局)
OPEP) Devices Market:
Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Strategic Insights
-
CAGR (2021 - 2028)5.2% -
Market Size 2021
US$ 125.66 Million -
Market Size 2028
US$ 179.34 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Allergan Plc
- PARI GmbH
- Smiths Medical
- AirPhysio
- D R BURTON HEALTHCARE
- Medica Holdings LLC
- CEGLA Medizintechnik GmbH Co KG
- Able Healthcare
- Trudell Medical International
Regional Overview
- 北米(米国、カナダ、メキシコ)
- ヨーロッパ(英国、ドイツ、フランス、ロシア、イタリア、その他のヨーロッパ)
- アジア太平洋(中国、インド、日本、オーストラリア、その他のアジア太平洋)
- 南米および中米(ブラジル、アルゼンチン、その他の中南米)
- 中東およびアフリカ(南アフリカ、サウジアラビア、UAE、その他の中東およびアフリカ)
Market Segmentation
CAGR (2021 - 2028) (2021 - 2028)5.2%- 市場規模 2021
1億2,566万米ドル - 市場規模 2028年
1億7,934万米ドル
市場の動向
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
主要人物
- アラガン
- PARI GmbH
- スミスメディカル
- エアフィジオ
- D?R バートン ヘルスケア
- メディカホールディングス
- CEGLAメディシンテクニック株式会社
- エイブルヘルスケア
- トゥルーデルメディカルインターナショナル
地域概要
- 北米
- ヨーロッパ
- アジア太平洋地域
- 南米と中央アメリカ
- 中東およびアフリカ
市場セグメンテーション
- マウスピースPEPデバイス
- フェイスマスクPEPデバイス
- ボトルPEPデバイス
- 慢性閉塞性肺疾患
- 病院薬局
- オンライン薬局
- 小売薬局
- サンプル PDF では、定性的および定量的な分析により、コンテンツの構造と情報の性質が紹介されています。
市場洞察
慢性閉塞性肺疾患(COPD)と喘息の罹患率増加が市場成長を後押し
COPD と嚢胞性線維症の発症率は世界中で上昇しています。世界保健機関 (WHO) によると、COPD の悪化は重大な事象です。COPD 関連の障害と死亡率は、OPEP デバイスの需要を促進しています。米国疾病管理予防センター (CDC) によると、2018 年には約 900 万人の成人が慢性気管支炎と診断されました。また、喘息はあらゆる年齢、性別、人種の人々に一般的になりつつあります。CDC によると、世界中で約 3 億人が喘息を患っており、2025 年までに 1 億人増えると予想されています。喘息の有病率、重症度、死亡率は米国全体で大きく異なります。米国では 2,500 万人以上が喘息を患っており、これは成人の 7.7%、子供の 8.4% に相当します。ニュージーランドのオークランドに関する 2018 年の世界喘息レポートによると、喘息は障害調整生存年数で評価すると、障害の最大原因の 16 位、疾病負担の最大原因の 28 位にランクされています。喘息は高所得国でよく見られますが、喘息関連の死亡の大半は低所得国と中所得国で発生しています。そのため、COPD と喘息の有病率の上昇により、OPEP デバイスなどの粘液除去デバイスの需要が高まり、振動式呼気陽圧 (OPEP) デバイス市場の成長が促進されます。
製品ベースの洞察
振動式陽圧呼気(OPEP)デバイス市場は、製品ベースで、マウスピースPEPデバイス、フェイスマスクPEPデバイス、ボトルPEPデバイスに分類されます。マウスピースPEPデバイスセグメントは、2021年に最大の市場シェアを占めました。さらに、予測期間中に市場で5.3%のCAGRを記録すると予想されています。マウスピースPEPは、肺から粘液を取り除くのに役立ちます。また、肺の虚脱を防いだり、虚脱した部分を開いたりすることもできます。マウスピースPEPデバイス市場を牽引する主な要因の1つは、高齢者人口の増加と、慢性閉塞性肺疾患(COPD)や喘息などの慢性疾患の発生率の上昇です。米国疾病管理予防センター(CDC)によると、2020年までに約900万人が慢性気管支炎と診断され、マウスピースデバイスの必要性が高まっています。
適応症の洞察
適応症に基づいて、振動式呼気陽圧(OPEP)デバイス市場は、慢性閉塞性肺疾患(COPD)、喘息、気管支炎、気管支拡張症、嚢胞性線維症、その他に分類されます。 COPDセグメントは2021年に最大の市場シェアを占めました。ただし、喘息セグメントは予測期間中に6.0%のCAGRを記録すると予想されています。 COPDは、進行性の気流制限と組織破壊を特徴とする一般的な治療可能な疾患です。これは、有害な粒子またはガス(最も一般的にはタバコの煙)への長期暴露による慢性炎症による肺の構造変化に関連しています。慢性炎症は気道狭窄と肺反動の減少を引き起こします。
製品の発売と承認は、企業が世界的な足跡と製品ポートフォリオを拡大するために一般的に採用されている戦略です。さらに、振動式呼気陽圧(OPEP)デバイス市場のプレーヤーは、顧客を拡大するためのパートナーシップ戦略に重点を置いており、これにより、ブランド名を世界的に維持することができます。市場は、市場プレーヤーによる革新的な製品の開発により、今後数年間で繁栄すると予想されています。
振動式呼気陽圧装置市場レポートの範囲
レポート属性 | 詳細 |
---|---|
2021年の市場規模 | 1億2,566万米ドル |
2028年までの市場規模 | 1億7,934万米ドル |
世界のCAGR(2021年~2028年) | 5.2% |
歴史的なデータ | 2019-2020 |
予測期間 | 2022-2028 |
対象セグメント | 製品別
|
対象地域と国 | 北米
|
市場リーダーと主要企業プロフィール |
|
- サンプル PDF では、定性的および定量的な分析により、コンテンツの構造と情報の性質が紹介されています。
企業プロフィール
- アラガン
- PARI株式会社
- スミスメディカル
- エアフィジオ
- D•Rバートンヘルスケア
- メディカホールディングス LLC
- CEGLAメディシンテクニック株式会社
- エイブルヘルスケア
- トゥルーデルメディカルインターナショナル
- マーキュリーメディカル
Oscillating Positive Expiratory Pressure (OPEP) Devices Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 125.66 Million |
Market Size by | US$ 179.34 Million |
Global CAGR | 5.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 製品(マウスピースPEPデバイス、フェイスマスクPEPデバイス、ボトルPEPデバイス) |
Regions and Countries Covered |
北米(米国、カナダ、メキシコ)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
COVID-19 was more likely to hospitalize those with moderate-to-severe or uncontrolled asthma. The coronavirus can cause pneumonia, blood clots, and acute respiratory distress syndrome, among other lung issues. The epidemic has added new levels of anxiety for both patients and clinicians for the nearly 37 million Americans who live with a chronic lung illness like asthma or chronic obstructive pulmonary disease. Caring for people with COVID-19 and underlying COPD is very difficult at this time. Certain treatments for COPD patients, such as nebulized bronchodilators and non-invasive ventilation (NIV), are thought to enhance the risk of viral transmission via aerosols. Although oscillating positive expiratory pressure (OPEP) devices have been in use with the increasing cases of COVID-19 in the region as studies shows oscillating positive expiratory pressure (OPEP) devices results in minimizing the effect of respiratory distress due to COVID. Also, the Positive Expiratory Pressure (PEP) flute therapy and Positive End-Expiratory Pressure (PEEP) proved to be led to a small yet statistically significant decrease in the severity of respiratory symptoms in adults with COVID-19 recovering at home as per various research studies.
North America held the largest share of the oscillating positive expiratory pressure (OPEP) devices market and is expected to continue its position over the coming years. These oscillating positive expiratory pressure (OPEP) devices are in high demand in North America's regional segment. Furthermore, the presence of a robust medical infrastructure and the early availability of new products and equipment are aiding the area market's overall development.
Trudell Medical International and Allergan Plc are the top two companies that hold huge market shares in the Oscillating Positive Expiratory Pressure (OPEP) Devices market.
The Oscillating Positive Expiratory Pressure (OPEP) Devices market majorly consists of players such as Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; D•R BURTON HEALTHCARE; Medica Holdings, LLC; CEGLA Medizintechnik GmbH & Co. KG; Able Healthcare; Trudell Medical International; Mercury Medical amongst others.
The hospital pharmacies segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 60.48% in 2021.
The mouthpiece PEP devices segment held the largest share of the market in the global oscillating positive expiratory pressure (OPEP) devices market and held the largest market share of 94.68% in 2021.
The chronic obstructive pulmonary disease (COPD) segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 34.60% in 2021.
Oscillatory positive expiratory pressure (OPEP) devices have been used as a supplement to traditional chest physiotherapy (CPT) to aid in the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. In chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome, the usage of OPEP devices is still limited. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices are said to help with sputum clearance.
Key factors that are driving the growth of this market are the growing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and rising technological advancements are expected to boost the market growth for oscillating positive expiratory pressure (OPEP) devices over the years.
The CAGR value of the oscillating positive expiratory pressure (OPEP) devices market during the forecasted period of 2021–2028 is 5.2%.
The List of Companies - Oscillating Positive Expiratory Pressure (OPEP) Devices Market
- Allergan Plc.
- PARI GmbH
- Smiths Medical
- AirPhysio
- D•R BURTON HEALTHCARE
- Medica Holdings, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- Able Healthcare
- Trudell Medical International
- Mercury Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.